Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYDRA II: Standard vs Short Hydration for CI-AKI Prevention
NCT04215042Unknown
- Sponsor
- Ospedale Misericordia e Dolce
- Start
- May 2016
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Randomised, open-label trial of sodium chloride in contrast-induced acute kidney injury (CI-AKI) (2 arms), sponsored by Ospedale Misericordia e Dolce. Primary endpoint: Incidence of Contrast Induced Acute Kidney Injury at 1 day. Status: unknown.
02
Drugs
sodium chloride
03
Conditions
contrast-induced acute kidney injury (CI-AKI)
Beyond the preview
Go deeper on NCT04215042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04215042.